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Abstract
AIM
To outline current evidence regarding prevention and 
treatment of parastomal hernia and to compare use of 
synthetic and biologic mesh.
METHODS
Relevant databases were searched for studies reporting 
hernia recurrence, wound and mesh infection, other 
complications, surgical techniques and mortality. Weighted 
pooled proportions (95%CI) were calculated using 
StatsDirect. Heterogeneity concerning outcome mea-
sures was determined using Cochran’s Q  test and was 
quantified using I 2. Random and fixed effects models were 
used. Meta-analysis was performed with Review Manager 
software with the statistical significance set at P  ≤ 0.05.
RESULTS
Forty-four studies were included: 5 reporting biologic mesh 
repairs; 21, synthetic mesh repairs; and 18, prophylactic 
mesh repairs. Most of the studies were retrospective 
cohorts of low to moderate quality. The hernia recurrence 
rate was higher after undergoing biologic compared to 
synthetic mesh repair (24.0% vs  15.1%, P  = 0.01). No 
significant difference was found concerning wound and 
mesh infection (5.6% vs  2.8%; 0% vs  3.1%). Open 
and laparoscopic techniques were comparable regarding 
recurrences and infections. Prophylactic mesh placement 
reduced the occurrence of a parastomal hernia (OR = 0.20, 
P  < 0.0006) without increasing wound infection [7.8% 
vs  8.2% (OR = 1.04, P  = 0.91)] and without differences 
between the mesh types. 
CONCLUSION
There is no superiority of biologic over synthetic mesh for 
parastomal hernia repair. Prophylactic mesh placement 
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during the initial surgery significantly reduces parastomal 
hernia occurrence regardless of the mesh type. 
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Core tip: This review and meta-analysis outlines all 
current evidence regarding prevention and treatment of 
parastomal hernia and compares the use of synthetic and 
biologic mesh. There is no superiority of biologic over 
synthetic mesh for parastomal hernia repair concerning 
parastomal hernia recurrence, wound infection and mesh 
infection. Prophylactic mesh placement during the initial 
surgery significantly reduces parastomal hernia occurrence 
regardless of the mesh type.
Knaapen L, Buyne O, van Goor H, Slater NJ. Synthetic vs 
biologic mesh for the repair and prevention of parastomal hernia. 
World J Meta-Anal 2017; 5(6): 150-166  Available from: URL: 
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INTRODUCTION
Parastomal hernia is a common complication of stoma 
formation during colorectal surgery, with incidences up 
to 50%. The risk of parastomal hernia is highest within 
the first few years after formation of the stoma but 
may develop as much as 20 years later[1]. Hernias are 
often asymptomatic and managed with conservative 
treatment. However, 11% to 70% of patients undergo 
surgery due to discomfort, pain, obstructive symptoms 
and cosmetic dissatisfaction[2]. These treatment per­
centages vary because surgeons are often reluctant to 
repair a parastomal hernia due to the high recurrence 
rate, complicated operation and co­morbidity of pa­
tients. Indeed, a parastomal hernia is regarded as a 
complex incisional hernia by hernia experts[3]. Hence, 
many patients suffer but never undergo surgery. 
The recurrence rate of parastomal hernia is the 
lowest after mesh repair (0%­33%), whereas primary 
fascial closure (46%­100%) and relocation of the stoma 
(0%­76%) result in much higher rates. Although low 
recurrence rates are reported after synthetic mesh 
repair, concerns have been raised regarding the safety 
of synthetic meshes in (potentially) contaminated 
fields due to the risk of mesh infection and subsequent 
removal. Other mesh­related complications include 
chronic infection, bowel stenosis, erosion of the mesh 
through the bowel and skin and enteroatmospheric 
fistulisation. These complications led to the development 
of biologic mesh, which due to its bio­degradable 
nature, has the potential to ameliorate these problems 
in infected and contaminated fields. 
The high prevalence of parastomal hernias and 
the difficulty of repair have led to a shift of focus from 
repair towards prevention using prophylactic mesh 
reinforcement at the time of stoma formation. However, 
prophylactic mesh placement coincides with risk of the 
same mesh­related morbidities of hernia repair.
There are no trials comparing biologic and synthetic 
mesh repair for parastomal hernias. Available studies 
show a large range in reported parastomal hernia 
recurrence rates and no difference in mesh type con­
cerning hernia recurrence or infection resistance[4­7].
No clear answer can be given as to whether there 
is a difference between the outcomes of synthetic and 
biologic mesh repair. However, given the financial costs 
of biologic mesh, the evidence for superiority and more 
beneficial outcomes compared to synthetic mesh is 
mandatory to support its use. 
There are various approaches regarding the an­
atomic position of the mesh during parastomal hernia 
repair. Meshes are implanted in an inlay, onlay, sublay 
or underlay (intraperitoneal) position. Laparoscopic 
repair involves the intraperitoneal technique, and open 
repair may involve any of the anatomical planes of 
the mesh. The inlay technique places the mesh within 
the fascial defect and is sutured to the fascial edges. 
With onlay repair, the mesh is placed subcutaneously 
and fixed onto the fascia of the anterior rectus sh­
eath and the aponeurosis of the external oblique 
abdominal muscle. When using a retromuscular or 
sublay technique, the prosthesis is placed dorsally 
to the rectus muscle and anteriorly to the posterior 
rectus sheath after mobilization of the latter. When 
performing intraperitoneal repair, the choice can be 
made between the Sugarbaker and keyhole repair 
techniques. Regarding the Sugarbaker technique, the 
hernia defect is closed with intraabdominal placement 
of the prosthetic mesh securely sutured or tacked to 
the abdominal wall. Between the abdominal wall and 
the prosthesis, the bowel is lateralized passing from 
the hernia sac into the peritoneal cavity[8]. During 
keyhole mesh repair, a 2­3 cm hole is fashioned in 
the mesh for passage of the stoma, and the rest of 
the mesh covers the entirety of the hernia orifice, 
including sufficient overlap (5 cm beyond the edge of 
the hernia defect is recommended). Both the keyhole 
and Sugarbaker techniques can be performed open or 
laparoscopically[9,10].
The primary aim of the current study was to compare 
biologic and synthetic mesh use for the treatment and 
prevention of parastomal hernia by systematic review 
and meta­analysis of available data in the literature. The 
secondary aim was to evaluate the different anatomical 
positions and surgical techniques used for parastomal 
hernia repair. With the absence of rigorous data focused 
on hernia recurrence in the literature, this review con­
tributes to the increased understanding of parastomal 
hernias.
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MATERIALS AND METHODS
Search strategy 
Articles for this review were identified by searching the 
electronic databases PubMed and Medline (January 
1946 to present) and by manual cross­reference 
searches. The last search was performed on 19­4­2016. 
The search included the following terms: “Parastomal 
hernia”, “Parastomal”, “Paracolostomy”, “Paraileostomy”, 
“Stoma” and “Colostomy” to represent the population. 
These terms were combined with terms relevant to 
the outcomes, such as “Ventral hernia”, “Defect”, 
“Mesh”, “Synthetic mesh”, “Biologic mesh”, “Closure”, 
“Reconstruction”, “Prosthesis”, “Scaffold”, “Prevention”
and “Prophylactic”. The full search strategy is provided 
in Appendix 1. No limitation to date or language was 
considered. Randomized and non-randomized studies 
were included. When multiple studies describing the 
same population were published, the most complete 
report was used. The systematic review was performed 
in accordance with PRISMA[11].
Critical appraisal
All selected papers were evaluated for methodological 
quality using the Cochrane risk-of-bias tool for ran-
domized controlled trials and the Newcastle­Ottawa 
Scale (NOS) for all non­randomized and single group 
studies[12,13]. Assessment using the Cochrane risk­of­
bias tool is based on sequence generation, allocation 
concealment, blinding of participants, personnel, 
outcomes assessors, incomplete outcomes data, selective 
outcomes reporting, and other sources of bias, such as 
baseline imbalance, early stopping bias, academic bias, 
and source of funding bias. The NOS is an instrument 
for assessing methodological quality and potential 
bias in non­randomized studies. A maximum of nine 
points were assigned to each study. Studies that scored 
four for selection, two for comparability, and three for 
assessment of outcomes were regarded as having a low 
risk of bias. Studies with two or three stars for selection, 
one for comparability, and two for outcome were 
considered as having a medium risk of bias. Any study 
with a score of one for selection or outcome, or zero for 
any of the three domains, was deemed as having a high 
risk of bias. A modification in the NOS was made for 
single group studies, which consisted of excluding the 
points for comparability with a maximum of six points: 
three for selection and three for outcome. After screening 
titles and abstracts, two reviewers (Knaapen L and Slater 
NJ) independently reviewed full­text articles for eligibility 
using the critical appraisal approach. Any disagreement 
was resolved by consensus with a third reviewer (van 
Goor). 
Outcome measures
Studies were identified according to the following 
inclusion criteria: Participants (human adults, minimum 
of 18 years of age), intervention (parastomal hernia 
repair with a synthetic or biologic mesh and prophylactic 
placement of mesh), and sufficient data available (10 or 
more patients).
The following criteria were used for exclusion: 
Stoma relocation, primary suture repair, and unspecified 
surgical technique. Studies published only as abstracts 
were excluded because quality assessment could not be 
performed.
The primary outcome measure was the recurrence 
rates of parastomal hernia as defined by the respective 
authors. Secondary outcomes were wound infection, 
mesh infection, mortality, other complications (medical 
and surgical), anatomic position of the prosthesis and 
surgical approach (open or laparoscopic). 
Data extraction and statistical analysis
All full­text articles that met the inclusion criteria were 
thoroughly reviewed, and the data for primary and 
secondary outcomes were extracted and recorded in 
a data form. Year of publication, study period, level of 
evidence, mean age, gender, number of patients included 
and evaluated, type of stoma, surgical technique (open 
or laparoscopic, anatomical mesh position, keyhole 
or Sugarbaker), type of mesh (biologic or synthetic) 
and duration of follow­up were also noted. Weighted 
pooled proportions with a 95%CI were determined 
for recurrence, wound infection, mesh infection, other 
complications and mortality using StatsDirect statistical 
software[14]. The heterogeneity concerning the outcome 
measures was determined with Cochran’s Q test and 
quantified using I2. A random­effects model was used 
unless heterogeneity was 0%, in which case, a fixed­
effects model was used. Meta­analysis was performed 
using Review Manager[15] with the statistical significance 
set at p < 0.05.
RESULTS 
A flowchart overview of the search including reasons 
for exclusion of studies is shown in Figure 1. A total 
of 44 studies were included. Five studies provided 
information on 84 biologic mesh repairs; 21 studies, 
on 669 synthetic mesh repairs; and 18 studies, on 500 
prophylactic mesh placements. 
The following were included in the current study: 
Seven randomized controlled studies (level 1 evidence; 
all prophylactic mesh repair), 5 non­randomized 
comparative studies (level 2 evidence) and 32 single­
group studies (level 3 evidence). Concerning the risk of 
bias assessment of seven randomized controlled trials 
(Figure 2): Sequence generation was unclear in 4 (57%) 
and low in 3 (43%) studies; allocation concealment 
was unclear in 1 (14%) and low in 6 (86%) studies; 
performance bias was high in all 7 (100%) studies; 
detection bias was low in 3 (43%) and high in 4 (57%) 
studies; attrition bias was low in all 7 (100%) studies; 
reporting bias was low in 6 (86%) and high in 1 (14%) 
study; and other bias was unclear in 2 (29%), low in 3 
(43%) and high in 2 (29%) studies.
The Newcastle-Ottawa Scale for quality assessment 
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showed that all 37 non­randomized studies had a low 
risk of bias for study selection. The five non-randomized 
two­group studies showed a low risk of bias regarding 
comparability in 1 study (20%), medium risk in 2 
studies (40%), and high risk in 2 studies (40%). The 
risk of bias for outcome assessment was low in 20 (54%) 
studies, medium in 15 (41%) studies, and high in two 
(5%) studies (Figure 3). 
Use of funding was not reported in 32 studies 
(73%). Five studies (11%) reported no funding[2,5,8,16,17]. 
Industry sponsored 4 biologic mesh studies (9%)[4,18­20]. 
The manufacturer supplied the mesh material in one 
biologic and one synthetic mesh study (5%)[21,22]. The 
state funded one study without financial disclosures 
reported[23]. Fifty­three percent of patients were female, 
and the mean age was 64.6 years. The indication for 
stoma placement was reported in 32 studies: benign 
disease in 9%, malignant disease in 68%, inflammatory 
bowel disease or diverticulitis in 19% and other causes 
in 4%. Patient demographics, study characteristics and 
critical appraisals are described in Table 1.
Biologic mesh repair of parastomal hernias 
Biological grafts used in the included studies were 
Surgisis, AlloDerm, Permacol and Peri­Guard (Table 
2). Five retrospective studies reported parastomal 
hernias that were repaired with a biologic mesh and 
included a combined enrolment of 84 patients. Patient 
follow­up ranged from 9­50 mo. One case of mortality 
was reported due to renal failure unrelated to the 
mesh[4]. Study characteristics and outcomes, including 
weighted­pooled rates of recurrence and wound­re­
488 records screened
135 full-text articles 
assessed for eligibility
44 studies included in 
qualitative synthesis
7 studies included in 
quantitative synthesis 
(meta-analysis)
91 articles excluded:
3 review/letter to editor
35 less than 10 patients
26 data could not be extracted
4 surgical technique/mesh was not specified
5 duplicate/ follow-up study
18 wrong topic
Records identified through 
database searching (n  = 484) 
Additional records identified 
through other sources (n  = 4)
353 records excluded
Figure 1  Search flow-chart following PRISMA.
Mesh repair No mesh repair Odds ratio Odds ratio
Study or subgroup Events Total Events Total Weight M-H, random, 95%CI M-H, random, 95%CI
Fleshman et al   6   49   7   53   20.7% 0.92 [0.29, 2.95]
Hammond et al   0   10   3   10     6.7% 0.10 [0.00, 2.28]
Jänes et al   2   15 17   21   13.7% 0.04 [0.01, 0.23]
López-Cano et al   9   18 15   16   10.9% 0.07 [0.01, 0.62]
Serra-Aracil et al   6   27 12   27   20.5% 0.36 [0.11, 1.17]
Târcoveanu et al   0   20   6   22     7.3% 0.06 [0.00, 1.18]
Viermaa et al   5   35 12   32   20.4% 0.28 [0.08, 0.91]
Total (95%CI) 174 181 100.0% 0.20 [0.08, 0.50]
Total events 28 72
Heterogeneity: Tau2 = 0.68; c 2 = 11.96, df = 6 (P  = 0.06); I 2 = 50%
Test for overall effect: Z  = 3.44 (P  = 0.0006)
Risk of bias
A  B   C  D   E  F   G
0.01          0.1             1              10           100
Favours (experimental)   Favours (control)
+
+ +
+
+
+
+
++ ++ ++
++ ++
++ +
+
+ +
+ +
+ ++-
-
-
-
-
-
-
-
-
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-
-
-
Figure 2  Incidence of parastomal hernia after prophylactic mesh placement vs no mesh placement. A: Random sequence generation (selection bias); B: 
Allocation concealment (selection bias); C: Blinding of participants and personnel (performance bias); D: Blinding of outcome assessment (detection bias); E: 
Incomplete outcome data (attrition bias); F: Selective reporting (reporting bias); G: Other bias.
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lated complications, are shown in Table 3. Five studies 
reported 23 hernia recurrences with a weighted­pooled 
proportion of 24% (95%CI: 8.6­44.1) (Figure 4). 
Only three of these studies reported treatment after 
recurrence. Araujo et al[24] relocated the stoma and, 
Ellis et al[19] reported a reoperation using a bioprosthetic 
not further specified. Taner et al[25] reported two asy­
mptomatic recurrences that were both treated con­
servatively. There were 4 wound infections that were 
reported with a weighted­pooled proportion of 5.6% 
(95%CI: 1.4­12.1)[4,18,25]. One was conservatively 
treated, one was treated with systemic antibiotics, and 
two were treated with local wound care[4,18,25]. No mesh 
infections were reported [0% (95%CI: 0­5.4)]. Other 
complications [13.4% (95%CI: 1.9­32.7)] were minor 
complications, including six seroma formations (four 
treated by drainage and two conservatively treated). 
Synthetic mesh repair of parastomal hernias 
Characteristics of the synthetic mesh used in the 
included studies are given in Table 2. One of the 21 
studies was a prospective trial that recruited 12 patients 
with synthetic mesh repair and 13 control patients 
without mesh repair. The other 20 studies had a com­
bined enrolment of 669 patients with synthetic mesh 
repairs[26]. Patient follow­up ranged from 7 to 51 mo. 
Table 1  Patient demographics, study characteristics and critical appraisal of included studies
Ref. Year Inclusion period Level of 
evidence
Mean age, 
years
Male (%) Newcastle-
Ottawa Scale
Cochrane risk of bias
Târcoveanu et al[44] 2014 2010-2011 1 NS NS ? ? - - + - ?
Ventham et al[63] 2012 2003-2010 2 I: 69, C: 68 I: 42%, C: 35% **** ** ***
Hansson et al[8] 2013 2005-2010 3 63 35% *** ***
López-Cano et al[40] 2012 2007-2010 1 I: 72, C: 66 I: 58%, C: 42% + + - + + + +
Hauters et al[16] 2012 2008-2010 3 69 (median) 40% *** ***
Fei et al[34] 2012 2008-2010 3 63 45% *** ***
Mizrahi et al[2] 2012 2005-2010 3 64 34% *** ***
Wara et al[5] 2011 1997-2008 3 62 (median) 50% *** ***
Janson et al[64] 2010 2003-2007 3 65 40% *** **
Jänes et al[42] 2010 2003-2006 2 63 66% **** **
Pastor et al[26] 2009 1999-2006 2 I: 60, C: 54 I: 42%, C: 54% **** * ***
Lüning et al[65] 2009 1997-2006 3 65 27% *** **
Serra-Aracil et al[6] 2009 2004-2006 1 I: 68, C: 67 I: 70%, C: 59% ? + - + + + -
Hansson et al[31] 2009 2002-2006 3 63 49% *** ***
Vijayasekar et al[45] 2008 2002-2007 3 61 52% *** ***
Jänes et al[43] 2009 2001-2003 1 I: 70, C: 71 I: 56%, C: 59% ? + - - + + -
Berger et al[35] 2009 2004-2008 3 69 (median) NS *** ***
Muysoms et al[27] 2008 2001-2007 2 70 54% **** * ***
Guzmán-Valdivia et al[32] 2008 NS 3 67 64% *** **
Berger[39] 2008 2006-2007 3 72 (median) 64% *** **
Craft et al[66] 2008 2004-2006 3 66 NS *** ***
Berger et al[7] 2007 1999-2006 3 70 (median) 39% *** ***
Mancini et al[29] 2007 2001-2005 3 60 44% *** **
Marimuthu et al[46] 2006 2002-2005 3 67 44% *** **
Gögenur et al[22] 2006 2003-2005 3 71 (median) 60% *** **
van Sprundel et al[37] 2005 2000-2003 3 57 31% *** ***
de Ruiter et al[33] 2005 1988-2002 3 NS NS *** ***
Longman et al[67] 2005 2000-2004 3 NS NS *** **
LeBlanc et al[28] 2005 NS 3 42-89 NS *** ***
Stelzner et al[36] 2004 1994-2002 3 70 (median) 60% *** **
Steele et al[30] 2003 1988-2002 3 64 50% *** ***
Hofstetter et al[38] 1998 NS 3 NS NS *** ***
Viermaa et al[23] 2015 2010-2013 1 I: 67 I: 51% + + - + + + +
C: 65 C: 54%
Asif et al[17] 2012 2004-2011 3 62 60% *** **
Figel et al[62] 2012 2005-2008 3 63 67% *** **
Smart et al[4] 2011 2007-2009 3 72 (median) 44% *** *
Taner et al[25] 2009 2006-2007 3 NS 39% *** **
Hammond et al[68] 2008 NS 1 I: 43, C: 50 I: 30%, C: 40% ? + - - + + ?
Hammond et al[21] 2008 NS 3 NS NS *
Aycock et al[18] 2007 2004-2006 3 56 36% *** **
Araujo et al[24] 2005 3 57 27% *** ***
Ellis et al[19] 2010 2004-2007 3 64 65% *** ***
Fleshman et al[20] 2014 2010-2012 1 I: 60, C: 59 I: 55%, C: 50% + + - + + + -
Williams et al[41] 2015 2011-? 2 I: 49, C: 59 I: 27%, C: 45% *** **
Level of evidence: 1: (Systematic reviews, meta-analyses) randomized controlled trials; 2: Two groups, non-randomized studies (e.g., cohort, case-control); 3: 
One group, non-randomized; 4: Descriptive studies that include analysis of outcomes; and 5: Case reports and expert opinion that include narrative reviews 
and consensus statements. NS: Not significant.
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One study did not specify mean or median follow­up. 
The overall mortality was 1.9% (11 patients, weighted­
pooled proportion, 95%CI: 0.9­3.2). None of the 
deaths were related to the mesh. Four post­operative 
deaths were due to progressive metastatic disease, 
two deaths were due to aspiration and subsequent 
cardiopulmonary arrest, and two deaths were due to 
secondary cardiopulmonary complications[8,27­29]. Wara 
et al[5] reported one death due to a neglected bowel 
injury that resulted in multiorgan failure and another 
death due to uncontrollable bleeding that resulted from 
portal hypertension that was unknown prior to surgery. 
One post­operative death was reported by Mizrahi et 
al[2] following sepsis that was not further specified and 
caused by an infected retroperitoneal haematoma, 
which necessitated a second operation.
Study characteristics and outcomes, including 
weighted pooled rates of recurrence and wound­related 
complications, are shown in Table 3. Nineteen studies 
Table 2  Characteristics of synthetic and biologic prostheses used for parastomal hernia repair
Name Material Coating Absorbable Pore size Weight
StomaMesh
Surgipro
Prolene
Central ring enforced 
polypropylene
Polypropylene None No Small to medium 0.8 mm or 
large 1.0-3.6 mm
Heavy weight 
or light weight
DUALMESH Composite multifilament 
expanded polytetrafluoroethylene
None No Very small 3/22 µm Heavy weight
Proceed Polypropylene
Encapsulated in polydioxanone
Oxidized 
regenerated 
cellulose
Partially
180 d and 28 d
Large Light weight
Parietex Composite multifilament 
Polyester/collagen
Type I collagen, 
polyethylene glycol, 
and glycerol layer
Partially 20 d Large > 3 mm Medium 
weight
ULTRAPRO Composite monofilament 
Polypropylene
Poliglecaprone-25 
(monocryl)
Partially 140 d Large > 3 mm Light weight
VICRYL Multifilament polyglactin None Yes, 60-90 d Small 0.4 mm Medium 
weight
Vypro Polypropylene PG910 Partially 42 d Large > 3 mm Light weight
Composix
Parastomal hernia patch
Polypropylene/expanded 
polytetrafluoroethylene
None No Medium 0.8 mm Light weight
DynaMesh Polypropylene PVDF Partially Large 1-2 mm Medium 
weight
Surgisis Porcine small intestine submucosa None
AlloDerm Human acellular dermis None
Permacol Cross-linked acellular porcine 
collagen
Yes, hexamethylene 
diisocyanate
Peri-Guard Bovine pericardium Yes; glutaraldehyde
STRATTICE Non-crosslinked porcine-derived 
acellular dermal matrix
None
37
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Figure 3  Quality assessment using the Newcastle-Ottawa Scale for risk of 
bias included in the systematic review. The absolute numbers of the studies 
are shown in boxes.
Proportion meta-analysis plot (random effects)
Smart et al
Taner et al
Aycock et al
Araujo et al
Ellis
Combined
0.56 (0.35, 0.75)
0.15 (0.02, 0.45)
0.27 (0.06, 0.61)
0.08 (1.9E-3, 0.36)
0.10 (0.01, 0.32)
0.24 (0.09, 0.44)
0.0            0.2           0.4            0.6           0.8
Proportion (95% confidence interval)
Figure 4  Proportion of hernia recurrences after biologic mesh repair of 
parastomal hernia. The square shape represents the weight of the study, and 
the horizontal line through the square represents the confidence interval of the 
effect estimate (random effects model; Cochran’s Q test = 15.8; I2 = 74.7%; P = 
0.0033).
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Table 3  Study characteristics and outcomes of synthetic mesh and biologic mesh repair of parastomal hernia n  (%)
Ref. No. patients 
(completed 
follow-up)
Type 
of 
stoma
Material; 
technique
Recurrence 
of parastomal 
hernia1
Wound infection Mesh 
infection
Other3 Mortality Follow-up 
(mo)
Mesh No mesh Mesh No mesh Mesh No mesh Mesh Mesh No mesh
Hansson et al[8] 61 - C: 55
I: 4
U: 2
L: 55; IPOM: SB;
ePTFE
4 (7) - 1 (2) - 1 (2) 21 (34) - 12 (2) 26
Fei et al[34] 11 - C: 6
I: 5
O: 11 Sublay: K;
PP
1 (9) - 0 - NS   3 (27) - 0 24
Mizrahi et al[2] 29 (28) - C: 18
I: 10
U: 1
L: 29 IPOM: K;
ePTFE
13 (46) - NS - 1 (4)   3 (11) - 12 (4) 28
Wara et al[5] 72 - C: 48
I: 24
L: 72 IPOM: K;
PP+ePTFE
2 (3) - 1 (1) - 3 (4) 20 (28) - 22 (3) 36
Pastor et al[26] 12 13 C: 10
I: 15
L: 12 O: 13 
IPOM:
K 3 SB: 7, lateral 
slit: 1
e-PTFE
  4 (33) 7 (54) 2 (17) 2 (15) 0 1 (8) 0 0 14
Lüning et al[65] 15 - C: 12
I: 3
O: 16 Onlay
PP 7; PE 6; 
VICRYL 1; CRE-
PPM 2
  3 (20) - 0 - 1 (7) 1 (7) - NS 33
Hansson et 
al[31]
55 - C: 47
I: 5
U: 3
L 55 IPOM; K
ePTFE
20 (36) - 0 - 2 (4) 29 (53) - 0 36 (median)
Berger et al[35] 47 - NS L: 46 O: 1 
Sandwich
PVDF-PP
1 (2) - 1 (2) - NS 3 (6) - 0 20 (median)
Muysoms et 
al[27]
24 - C:20
I: 4
L: 24 IPOM K:11 
non-slit SB 13
Parietex 11; 
DUALMESH 10; 
Composix 3
10 (42) - NS - NS 2 (8) - 52 (21) K: 31
SB: 14
Guzmán-
Valdivia et 
al[32]
25 - C:25 O: 25; Sublay
PP
2 (8) - 2 (8) - 0 2 (8) - 0 12
Craft et al[66] 21 - C: 5
I: 7
U: 9
L: 21; IPOM K: 5 
SB: 16
DUALMESH
1 (5) - 1 (5) -   2 (10)   8 (38) - 0 14
Berger et al[7] 66 - C:58
I:7
U:1
L: 66; IPOM SB: 
41 Sandwich: 25
DUALMESH 
(until 
4-2004) and 
Polyvinylidene
  8 (12) - 1 (2) - 2 (3) 5 (8) - 0 24 (median)
Mancini et 
al[29]
25 - C: 15
I: 5
U: 6
L: 25; IPOM SB
DUALMESH
1 (4) - 1 (4) - 1 (4)   3 (12) - 12 (4) 19 (median)
van Sprundel 
et al[37]
16 - C: 8
I: 5
U: 4
O: 16; IPOM K
DUALMESH
1 (6) - 0 - 0   5 (31) - 0 29 (median)
de Ruiter et 
al[33]
46 - C: 46 O: 46 Onlay
CRE-PPM
  7 (15) - 0 - 3 (7) 2 (4) - 0 51
Longman et 
al[67]
10 - C: 7
I: 3
O: 10 Sublay K
PP
0 - 0 - 0   1 (10) - 0 30 (median)
LeBlanc et al[28] 12 - C: 8
I: 2
U: 2
L: 12 IPOM SB 7, 
K 5 e-PTFE
1 (8) - 0 - 0   2 (17) - 12 (8) 20
Stelzner et al[36] 20 (19) - C: 20 O: 20 IPOM SB
e-PTFE
  3 (16) - 1 (5) - 0   3 (16) - 0 42
Steele et al[30] 58 - C: 31
I: 27
O: 58 Onlay 
“Stove pipe hat” 
PP
15 (26) - 2 (3) - 0   9 (16) - 0 51
Hofstetter et 
al[38]
13 - C: 13 O: 13 IPOM K
e-PTFE
0 - 0 - 0 0 - 0 NS
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reported 108 hernia recurrences after mesh repair 
with a weighted­pooled proportion of 15.1% (95%CI: 
9.7­21.6) (Figure 5). From the 19 studies that described 
hernia recurrence, 10 studies reported treatment. 
Three studies described 34 reoperations because of 
symptomatic hernia not further specified[30­32]. Two 
studies reported 2 patients who required reoperation 
that involved relocation of their stoma and mesh 
repairs[27,28]. Van Sprundel et al[33] noted one hernia 
recurrence due to a wide circle cut in the mesh, and in 
a second operation, the hernia content was removed, 
and the circle was narrowed with sutures. Ruiter and 
co­workers reported 5 patients who had the prosthesis 
definitively removed (not specified), 1 patient who had 
a smaller­sized prosthesis implanted and 1 patient who 
had only the hernia sac closed after midline laparotomy. 
Muysoms et al[27] noted one patient with a recurrence 
in whom a second laparoscopy was performed because 
of obstructive symptoms and was treated with a 
modified Sugarbaker technique. Another patient needed 
a laparotomy for a colonic abscess due to Crohn’s 
disease. After colonic resection and mesh removal, a 
translocation of the colostomy was performed. Two 
reoperations for parastomal hernia recurrences were 
described by Fei et al[34] and Berger et al[35] due to the 
breakdown of the sutures used for closing and keeping 
the mesh in place. Berger et al[35] reported three other 
patients who were treated with the sandwich technique 
and one with the Sugarbaker technique. All other 
described hernia recurrences were asymptomatic and 
treated conservatively.
Surgical wound infection was mentioned in eleven 
studies reporting 17 patients with a weighted­pooled 
proportion of 2.8% (95%CI: 1.6­4.4). Four studies 
reported treatment of wound infection[5,26,29,32]. Two 
patients were treated by surgical drainage, and five 
were treated with systemic antibiotics. Pastor et al[26] 
reported 1 patient with a parastomal abscess and 
subsequent fistula development repaired by laparotomy, 
transection of the fistula tract, and re­siting of the 
ileostomy[26]. Sixteen mesh infections were observed 
with a weighted­pooled proportion of 3.1% (95%CI: 
1.8­4.6), resulting in mesh removal from 14 patients. 
Other complications [17.8% (95%CI: 12.0­24.4%)] 
were seroma (31.1%), cardiopulmonary event (8.3%), 
urinary tract infection (0.8%), cutaneous/fascial dehi­
scence (0.8%), stoma complications (6.1%), ileus 
(9.9%), peritonitis (2.3%), post­operative bleeding 
(3.8%), haematoma (4.5%), bowel stenosis (14.4%), 
fistula formation (1.5%), renal failure (3%) and other 
(13.6%). Five of the 41 seromas were treated by 
surgical drainage, 12 were conservatively treated, and 
24 did not have any reported treatment[8,32,34,35].
Comparison of biologic mesh repair and synthetic 
mesh repair: When comparing the prevalence of 
Asif et al[17] 33 C: 12
I: 21
L: 33 SB:14 K:19
DUALMESH
11 (33)4 - 4 (12) 0 9 (27) 0 SB: 7
K: 36
Weighted 
pooled % 
(95%CI)
15.1% 
(9.7-21.6)
2.8% 
(1.6-4.4)
3,1% 
(1.8-4.6) 
FE
17,8% 
(12.0-24.4)
1.9 
(0.9-3.2)
Smart et al[4] 27 - C: 20 
I:7
O: 20
Onlay: K; 
Permacol
15 (55) - 1 (4) - 0 0 - 12 (4) 17
Taner et al[25] 13 - NS O: 13
Overlay + 
Underlay 
(sandwich)
AlloDerm
2 (15) - 1 (8) - 0 4 (31%) - 0 10
Aycock et al[18] 11 - C:2
I:9
O: 11
Inlay 8; Onlay 3;
AlloDerm
3 (27) - 2 (18) - NS 1 (9) - 0 9
Araujo et al[24] 13 - C: 13 O: 13
Onlay; Peri-
Guard
1 (8) - 0 - NS NS - 0 50
Ellis[19] 20 - C: 17
I: 3
O: 20
IPOM; SB; 
Surgisis
2 (10) - 0 - 0 4 (20) - 0 18
Weighted 
pooled % 
(95%CI)
24% 
(8.6-44.1)
5.6% 
(1.4-12.1)
0% 
(0-5.4) 
FE
13.4% 
(1.9-32.7)
2.6% 
(0.3-6.9) 
FE
Synthetic mesh repair: 1With regard to lost after follow-up; 2Unrelated to mesh; 3Seroma 41 (48, 74, 121, 149, 171, 178, 201, 257); Cardiopulmonary 11 (48, 
121, 171, 203, 487); Urinary tract infection 1 (243); Cutaneous/ fascial dehiscence 1 (252); Stoma complication 8 (121, 243, 245, 285); Ileus 13 (48, 87, 171, 212, 
272); Post-operative bleeding 5 (48, 121, 171); Haematoma 6 (74, 171); Bowel stenosis 19 (121, 161, 178, 203, 207, 243, 272, 285, 487); Fistula formation 2 (285); 
Renal failure 4 (179, 203); Peritonitis 3 (121, 171); Other 18 (87, 171, 203, 207, 212, 243, 257, 272, 487); 4All keyhole. Biologic mesh repair: 1With regard to lost 
after follow-up; 2Unrelated to mesh; 3Complications other: Seroma 6 (165, 429), Incisional separation 2 (165), Epidural infection 1 (242). FE: Fixed-effect 
model. L: Laparoscopic; O: Open; C: Colostomy; I: Ileostomy; SB: Sugarbaker; K: Keyhole PP: Polypropylene mesh; IPOM: Intraperitoneal mesh; PCM: 
Parietex composite mesh; ePTFE: Expanded polytetrafluoroethylene; CRE-PPM: Central ring enforced polypropylene mesh; PP + ePTFE: Polypropylene-
based mesh covered with ePTFE.
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hernia recurrence, synthetic mesh repair resulted in 
a significantly lower rate compared to biologic mesh 
repair (OR = 1.96; 95%CI: 1.16-3.30; p = 0.01). No 
significant difference was found concerning wound 
infection (OR = 1.76; 95%CI: 0.58-5.38; p = 0.32), 
mesh infection (OR = 0.29; 95%CI: 0.02-4.83; p = 
0.39) or other complications (OR = 0.59; 95%CI: 
0.29­1.22; p = 0.15) (Table 4). 
Anatomic position of the prosthesis
Various mesh positions were applied concerning bio­
logic mesh repair, including inlay, onlay, sublay and 
underlay (intraperitoneal) placement of the mesh. 
Two retrospective series reported on 40 cases that 
involved onlay mesh repairs. Hernias recurred in 31.3% 
(weighted pooled proportion, 95%CI: 0.9­78.8) of 
patients. Smart et al[4] placed 16 stomas lateral to 
the rectus sheath, which showed a high recurrence 
rate (75%) compared to 11 stomas within the rectus 
sheath (27%)[4,24]. Ellis et al[19] placed the mesh 
intraperitoneally using the Sugarbaker technique. Two 
of 20 (10%) patients had a recurrent hernia after a 
Table 4  Summary of pooled proportions of outcome measures of biologic mesh repair vs  synthetic mesh repair
Hernia repair No of studies No of mesh repairs Recurrence Complications
Wound infection Mesh infection Other
Biologic mesh   5   84   24% (8.6-44.1)   5.6% (1.4-12.1) 0% (0-5.4) FE 13.4% (1.9-32.7)
Synthetic mesh 21 669 15.1% (9.7-21.6) 2.8% (1.6-4.4) 3.1% (1.8-4.6) FE   17.8% (12.0-24.4)
P value 0.01 0.32 0.39 0.15
Two-tailed Fisher’s exact test was used because of too small frequencies. FE: Fixed-effect model.
Hansson et al
Fei
Mizrahi et al
Wara et al
Pastor et al
Lüning et al
Hansson et al
Berger et al
Muysoms et al
Guzmán-Valdivia et al
Craft et al
Berger et al
Mancini et al
van Sprundel et al
de Ruiter et al
Longman et al
LeBlanc et al
Stelzner et al
Steele et al
Hofstetter et al
Asif et al
Combined
0.07 (0.02, 0.16)
0.09 (2.3E-3, 0.41)
0.46 (0.28, 0.66)
0.03 (3.4E-3, 0.10)
0.33 (0.10, 0.65)
0.20 (0.04, 0.48)
0.36 (0.24, 0.50)
0.02 (5.4E-4, 0.11)
0.42 (0.22, 0.63)
0.08 (9.8E-3, 0.26)
0.05 (1.2E-3, 0.24)
0.12 (0.05, 0.22)
0.04 (1.0E-3, 0.20)
0.06 (1.6E-3, 0.30)
0.15 (0.06, 0.29)
0.00 (0.00, 0.31)
0.08 (2.1E-3, 0.38)
0.16 (0.03, 0.40)
0.26 (0.15, 0.39)
0.00 (0.00, 0.25)
0.33 (0.18, 0.52)
0.15 (0.10, 0.22)
Proportion meta-analysis plot (random effects)
0.0                        0.2                        0.4                        0.6                        0.8
Proportion (95%CI)
Figure 5  Proportion of hernia recurrences after synthetic mesh repair of parastomal hernia. The square shape represents the weight of the study, and the 
horizontal line through the square represents the confidence interval of the effect estimate (random-effects model; Cochran’s Q test = 90.8; I2 = 78%; P ≤ 0.0001).
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follow-up of 18 mo. The sandwich technique, which 
combines the onlay and sublay technique, was reported 
by Taner et al[25]. After a mean follow­up of 10 mo, two 
of 13 (15%) patients had a recurrent hernia. One other 
study reported multiple surgical techniques (including 
inlay and onlay) and did not allow for stratified outcome 
extraction[18]. Considering the anatomical position for 
open synthetic mesh repair, 3 retrospective studies 
using a series of onlay synthetic mesh repairs, reporting 
a total of 119 repairs, were included in this study. 
Hernias recurred in 21.5% (weighted pooled proportion, 
95%CI: 14.7­29.3) of patients. In three studies, the 
mesh was placed in the sublay position, and 3 hernia 
recurrences with a weighted­pooled proportion of 8.1% 
(95%CI: 2.1­17.4) were reported. 
The mesh was placed intraperitoneally by the open 
approach in three studies reporting 48 repairs (19 
Sugarbaker and 29 keyhole technique repairs)[36­38]. 
The weighted­pooled proportion of recurrence was 
8.8% (95%CI: 1.8­20.2). Seven studies described 
laparoscopic synthetic mesh repair using the Sugar­
baker technique, and the weighted-pooled proportion of 
hernia recurrence was 10.9% (95%CI: 3.7­21.4). The 
keyhole technique was used in 8 studies, and hernia 
recurrence was reported in 35.6% (weighted pooled 
proportion; 95%CI: 14.6­60.1).
Surgical approach
All biologic mesh repairs were via the open approach. 
Considering the surgical approach used for synthetic 
mesh repair, 9 studies reported open repairs, 10 studies 
reported laparoscopic repairs, and 2 studies reported 
combined open and laparoscopic repairs. Unfortunately, 
separate data of the different approaches in these last 
two studies could not be extracted. Within the nine 
studies that reported 213 open synthetic mesh repairs, 
hernias recurred in 13.5% (weighted pooled proportion; 
95%CI: 8.1­20.2) of patients. Wound infection, mesh 
infection and other complications were reported in 3% 
(95%CI: 1.2­5.7), 2.3% (0.7­4.8) and 12.8% (95%CI: 
7.4­19.4) of the cases, respectively. Ten studies re­
ported 397 laparoscopic synthetic mesh repairs. The 
weighted­pooled proportion of hernia recurrence was 
18% (95%CI: 8.9­29.5). Wound infection, mesh 
infection and other complications were reported in 
2.4% (95%CI: 0.8­4.8), 3.6% (95%CI: 1.9­5.7) and 
23.8% (95%CI: 14.5­34.6) of the cases, respectively. 
Comparison of surgical approach: Comparing 
open vs laparoscopic mesh repair did not result in 
a significant difference in hernia recurrence (OR = 
0.81; 95%CI: 0.51­1.28; p = 0.37), wound infection 
(OR = 1.17; 95%CI: 0.38-3.62; p = 0.79) or mesh 
infection (OR = 0.67; 95%CI: 0.21-2.14; p = 0.50). 
A significantly (OR = 0.39; 95%CI: 0.25-0.63; p ≤ 
0.0001) lower occurrence rate of other complications 
was observed with open repair (Table 5). Regarding 
laparoscopic synthetic mesh repair, the Sugarbaker 
technique resulted in a significantly lower recurrence 
rate of parastomal hernia compared to the keyhole 
technique (OR = 0.35; 95%CI: 0.21-0.59; p ≤ 0.0001).
Prophylactic mesh placement
Eighteen studies reported a total of 500 prophylactic 
mesh placements, which included 13 studies consisting 
of 382 patients with synthetic mesh repair and 5 studies 
consisting of 118 patients with biologic mesh repair. The 
follow­up ranged from 7­65 mo.
The overall mortality was 2.5% (21 deaths, weighted 
pooled proportion, 95%CI: 1.3­4.2) None of the deaths 
were related to the mesh. Two postoperative deaths 
were due to progressive metastatic disease, one was 
due to a pulmonary thromboembolism, and two were 
due to cardiopulmonary complications[22,23,39­41]. Jänes et 
al[42] reported five deaths due to septic or cardiovascular 
complications not further specified. Fleshman et al[20] 
described eleven deaths, none of which were related to 
the device or treatment not further specified. 
Study characteristics and outcomes, including wei­
ghted­pooled rates of hernia occurrence and wound­
related complications, are shown in Table 6. When 
comparing prophylactic placement of biologic mesh with 
synthetic mesh, there was no significant difference in 
hernia occurrence (OR = 0.79, 95%CI: 0.40-1.55; p = 
0.49) or wound infection (OR = 0.30, 95%CI: 0.07-1.28; 
p = 0.10). In the mesh group, 58 hernia occurrences 
were observed with a weighted­pooled proportion of 
11.5% (95%CI: 7.1­16.8) (Figure 6) and 31 wound 
infections with a weighted­pooled proportion of 6.9% 
(95%CI: 3.6­11.1), and no infections of the prosthesis 
were reported [0% (95%CI: 0­2.0)]. 
From the 15 studies reporting hernia occurrence, 9 
elaborated on treatment received. Five studies reported 
21 reoperations because of a symptomatic hernia not 
further specified[6,20,23,40,43]. Two studies reported 5 
Table 5  Summary of pooled proportions of outcome measures of open synthetic mesh repair vs  laparoscopic synthetic mesh repair
FE: Fixed-effect model.
Hernia repair No. of studies No. of mesh 
repairs
Recurrence Complications
Wound infection Mesh infection Other
Open repair   9 213 13.5% (8.1-20.2)   3% (1.2-5.7) FE 2.3% (0.7-4.8) FE 12.8% (7.4-19.4)
Laparoscopic repair 10 397   18% (8.9-29.5) 2.4% (0.804.8) FE 3.6% (1.9-5.7) FE   23.8% (14.5-34.6)
P value 0.37 0.79 0.5 ≤ 0.0001
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patients who underwent reoperation involving relocation 
of stoma and mesh repairs[44,45]. All other reported 
hernia occurrences were asymptomatic and treated 
conservatively[6,16,22,45]. Six studies reported treatment 
of a wound infection[6,22,39,42,45,46]. Sixteen patients 
were treated conservatively, 7 patients were treated 
by surgical drainage, and 2 patients were treated 
with systemic antibiotics. Other complications were 
seroma (7%), cardiopulmonary event (4.7%), urinary 
tract infection (5.4%), cutaneous/fascial dehiscence 
(3.9%), stoma necrosis (12.4%), intra­abdominal/
pelvic infection (1.6%) stoma­related problems (1.6%), 
miscellaneous (20.9%) and severe events not further 
specified (39.5%). All nine reported seromas were 
treated by surgical drainage[44]. 
Meta­analysis was performed on the data concer­
ning the incidence of parastomal hernia in the seven 
randomized controlled trials (Figure 2). Overall, para­
stomal hernias occurred significantly less in the pro­
phylactic group (weighted­pooled proportion 14.9%; 
95%CI: 6.1­26.6) compared to the conventional sto­
ma group (46.8%; 95%CI: 24.7-69.7) (OR = 0.20; 
95%CI: 0.08­0.50; p = 0.0006). Concerning the use 
of prophylactic biologic mesh repair or synthetic mesh 
repair, there was no significant difference in parastomal 
hernia occurrence (OR = 0.48; 95%CI: 0.18-1.25; p = 
0.13). Additionally, there was no significant difference 
found between both groups (7.8%; 95%CI: 1.8­17.5 
vs 8.2%; 95%CI: 4.2­13.4) regarding wound infection 
(OR = 1.04 95%CI: 0.53-2.02; p = 0.91 FE). 
Anatomic position of the prosthesis: Considering 
the surgical technique used for prophylactic mesh repair, 
12 studies reported open reinforcement, and 3 studies 
reported laparoscopic reinforcement. Unfortunately, 
separate data of 2 studies combining open and laparo­
scopic reinforcement and 1 study combining the onlay 
and sublay techniques did not allow for stratification of 
outcomes.
Williams et al[41] used the stapled mesh stoma 
reinforcement technique (SMART) and reported 
21 prophylactic mesh placements and 4 hernia oc­
currences.
In eleven studies, of which ten reported open and 
Târcoveanu et al
Ventham 
López-Cano et al
Hauters et al
Figel et al
Janson et al
Jänes et al
Serra-Aracil et al
Vijayasekar et al
Jänes et al
Hammond et al
Hammond et al
Berger 
Marimuthu et al
Gögenur et al
Vierimaa et al
Fleshman et al
Williams et al
Combined
0.00 (0.00, 0.17)
0.35 (0.14, 0.62)
0.50 (0.26, 0.74)
0.05 (1.3E-3, 0.25)
0.00 (0.00, 0.21)
0.12 (0.03, 0.31)
0.13 (0.06, 0.24)
0.22 (0.09, 0.42)
0.10 (0.03, 0.23)
0.13 (0.02, 0.40)
0.00 (0.00, 0.31)
0.07 (1.7E-3, 0.32)
0.00 (0.00, 0.14)
0.00 (0.00, 0.19)
0.08 (0.01, 0.27)
0.14 (0.05, 0.30)
0.12 (0.05, 0.25)
0.19 (0.05, 0.42)
0.12 (0.07, 0.17)
0.0                             0.2                            0.4                              0.6                            0.8
Proportion (95%CI)
Figure 6  Proportion of hernia occurrence after prophylactic mesh placement. The square shape represents the weight of the study, and the horizontal line 
through the square represents the confidence interval of the effect estimate (random-effects model; Cochran’s Q test = 45.5; I2 = 62.7%; P = 0.0002).
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Table 6  Study characteristics and outcomes of prophylactic mesh placement of parastomal hernia n  (%)
Ref. No. Patients 
(completed 
follow-up)
Type of 
stoma
Material; 
technique
Parastomal hernia1 Wound infection Mesh 
infection
Other3 Mor-
tality
Follow-up 
(mo)
Mesh No 
mesh
Mesh No mesh Mesh No mesh Mesh Mesh No mesh
Târcoveanu 
et al[44]
20 22 C: 42 O: 42;
Sublay; PP
0 6 (27) 0 2 (9) 0 9 (45) 11 (50) 0 9 (median)
Ventham et 
al[63]
17 24 C: 42 O: 42;
Sublay;
PP
6 (35) 13 (54) 2 (12%) 1 (4) NS 0 0 0 12
López-Cano 
et al[40]
19 (18) 17 (16) C: 36 L: 36;
IPOM; SB;
Proceed
9 (50) 15 (94) 8 (44) 3 (19) 0 16 (89) 5 (31) 12 (3) 12
Hauters et 
al[16]
20 - C: 20 L: 17 O: 3;
IPOM; SB: 
20;
PCM
1 (5) - 0 - 0 6 (30) - 0 24
Figel et al[62] 16 - C: 16 O: 16;
IPOM; SB: 12; 
K: 4;
Surgisis
0 - 0 - 0 NS - 0 38 
(median)
Janson et 
al[64]
25 - C: 25 L: 25; Sublay; 
ULTRAPRO
3 (15) - 2 (8) - 0 1 (4) - 0 19
Jänes et al[42] 75 (61) 18 (12) C: 79 I: 
14
O: 93; Sublay; 
ULTRAPRO
8 (13) 8 (67) 6 (8) 4 (22) 0 0 0 52 (5) 15
Serra-Aracil 
et al[6]
27 27 C: 54 O: 54; Sublay; 
ULTRAPRO
6 (22) 12 (44) 4 (15) 4 (15) 0 1 (4) 1 (4) 0 29
Vijayasekar 
et al[45]
42 - C: 33
I: 9
O: 42; Sublay; 
PP
4 (10) - 1 (2) - 0 1 (2) - 0 31
Jänes et al[43] 27 (15) 27 (21) C:54 O: 54; 
Sublay;
Vypro
2 (13) 17 (81) 0 0 0 0 0 0 65
Hammond 
et al[68]
10 10 NS O: 20; Sublay; 
Permacol
0 3 (30) 0 0 0 0 0 0 6.5
Hammond 
et al[21]
15 - NS O: 15; Onlay: 
6; Sublay 9; 
Permacol
1 (7) - NS - NS NS - 0 7 (median)
Berger[39] 25 (24) - C: 24
I: 1
L: 6, O: 19;
IPOM; K; 
DynaMesh
0 - 0 - 0 0 - 12 (4) 11
Marimuthu 
et al[46]
18 - NS O: 18; Sublay; 
Surgipro
0 - 1 (6) - 0 1 (6) - 0 16
Gögenur et 
al[22]
25 (24) - C: 25 O: 25; Sublay; 
StomaMesh
2 (8) - 4 (17) - 0 6 (25) - 12 (4) 12
Vierimaa et 
al[23]
42 (35) 41 (32) C: 83 L: 83;
IPOM; K;
DynaMesh
5 (14) 12 (38) 1 (3) 2 (6) NS 9 (21) 10 (24) 12 (1) 12
Fleshman et 
al[20]
55 (49) 58 (53) C: I:23/ 
C:35
I: I:19/
C:36
O: 113;
Sublay;
STRATTICE
6 (12) 7 (136) 2 (4) 3 (6) 0 21 (38) 30 (52) 112 (10) 24
Williams et 
al[41]
22 (21) 11 C: I:4/ 
C:7
I: I:11/ 
C:11
I: O = 18 L = 4
C: O = 11
SMART 
Onlay; 
Permacol
4 (19) 8 (73) NS NS 0 2 (9) 0 12 (3) I: 18
C: 9
Weighted 
pooled %; 
(95%CI)
11.5% 
(7.1-16.8)
51.5% 
(33.7-69.1)
6.90%
(3.6-11.1)
9.30%
 (4.8-15.1)
0%
 (0-2.0) 
FE
14.20%
(5.5-26.0)
13.80%
(3.0-30.7)
2.6%
(1.3-4.4)
1With regard to lost after follow-up; 2Unrelated to mesh; 3Seroma 9 (10); Cardiopulmonary event 6 (10, 436); Urinary tract infection 7 (10, 436); Cutaneous/
fascial dehiscence 5 (53, 231,436); Stoma (mucosal/intestinal) necrosis 16 (53, 126, 163, 173, 227,436); Intra-abdominal/pelvic infection 2 (436, 489); Intestinal 
occlusion 4 (436,489); Stoma-related problems 2 (436); Other 27 (10, 53, 54, 231); Severe events not further specified 51 (488). L: Laparoscopic; O: Open; C: 
Colostomy; I: Ileostomy; SB: Sugarbaker; PP: Polypropylene mesh; IPOM: Intraperitoneal mesh; PCM: Parietex composite mesh; SMART: Stapled mesh 
stoma reinforcement technique.
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one reported laparoscopic reinforcements, the mesh 
was placed in the sublay position, and 37 hernia oc­
currences with a weighted pooled proportion of 11.5% 
(95%CI: 6.9%­17.1%) were reported. The mesh 
was placed intraperitoneally in three studies. Figel et 
al[62] used the open intraperitoneal surgical technique 
and reported 16 stoma reinforcements without hernia 
occurrences. Two studies reported the laparoscopic 
surgical reinforcement technique. Lopez-Cano et al[40] 
used the Sugarbaker technique and reported 18 mesh 
placements and 9 (50%) hernia occurences. Vierimaa 
et al[23] used the keyhole technique and reported 35 
mesh placements and 5 (14%) hernia occurrences. 
DISCUSSION
The current study evaluated and compared all the 
evidence regarding the use of biologic and synthetic 
mesh for repair and prevention of parastomal hernia. 
Interestingly, the results of comparing biologic and 
synthetic mesh repairs showed a comparable or even 
superior result regarding parastomal hernia recurrence 
(24% vs 15.1%) and wound infection (5.6% vs 2.8%) 
in favour of the synthetic mesh repair. Overall, the mesh 
infection rate was low. Only sixteen mesh infections 
were reported in 753 repairs (2.1%), which resulted 
in fourteen mesh removals (all synthetic meshes). 
However, these observations should be interpreted 
cautiously because of the low to moderate quality of the 
studies.
Biologic mesh has gained widespread popularity in 
the context of infection and a contaminated environment 
because of their proposed advantages, including bio­
compatibility resulting in rapid vascularization and 
migration of host (immune) cells. It is thought that 
biologic prostheses are therefore less susceptible to 
infection than their synthetic counterparts. The ventral 
hernia working group regards parastomal hernia repair 
as potentially contaminated (grade 3) and therefore 
recommends biologic mesh repair[47]. Many authors 
believe that synthetic mesh should not be used in a 
contaminated environment or in close proximity to 
the bowel and stoma due to the risk of erosion and 
fistula formation. However, studies with high­level 
evidence are lacking, and the exact origins of these 
concerns are difficult to identify, are mostly anecdotal 
or reference old reports using inferior materials and 
techniques[48­50]. Primus and Harris criticized the surgical 
literature on the use of biologics in contaminated fields, 
arguing that cumulative data do not support the claim 
that biologics are indicated for use in contaminated 
fields. The primary literature varies widely in terms of 
sample size, diagnosis of (recurrent) PSH, methods 
of mesh placement, follow­up period, reported hernia 
recurrences and surgical site infection[51]. Rosen et al[52] 
reported a critical review of the surgical literature on 
biologic mesh repair, which revealed that the majority 
of the studies evaluating the outcomes of biologic mesh 
are actually reporting the repair of clean defects. This 
finding is very surprising given the high costs of biologic 
mesh, whereas the position of synthetic mesh in “clean”
hernia repair has been proven. Despite the lack of high­
grade evidence, biologic meshes are still preferred 
above synthetic mesh in contaminated fields as noted 
by Bondre et al[53], who conducted a multicentre study 
about practice patterns in contaminated ventral hernia 
repair. This review shows a comparable to superior 
result of synthetic mesh over biologic mesh concerning 
parastomal hernia recurrence. This finding is confirmed 
by Lee et al[54] in a systematic review on ventral hernia 
mesh repair in contaminated fields. Mesh removal 
due to infection is a much­feared complication. The 
literature suggest that biologic mesh does not prevent 
infection but can be more easily salvaged when infection 
arises[55]. This review challenges the concept that 
contaminated hernias should be repaired with expensive 
biologic mesh. Only sixteen mesh infections were seen 
in this current review, resulting in mesh removal from 
14 patients. Concerning parastomal hernia repair, 
surgeons should carefully balance the risks and costs 
with the benefits when deciding on the choice of mesh 
for parastomal hernia repair.
Similar to ventral hernia repair, the prosthesis is 
placed in either the inlay, onlay, sublay, or underlay 
(intraperitoneal) position during parastomal hernia 
repair. None of the included studies used an inlay 
placement of the prosthesis. Onlay mesh repair showed 
the highest recurrence rate, whereas the sublay tech­
nique showed the lowest in the current study. There 
was no difference in wound and mesh infection rates 
between the various anatomic positions. However, firm 
conclusions cannot be drawn based on this subanalysis 
because these results were obtained from small groups. 
Each method of mesh repair has its own theoretical 
advantages and disadvantages. Laparotomy is avoided 
with the onlay technique, but it requires extensive 
dissection of subcutaneous tissue, which predisposes 
patients for haematoma and seroma formation. Dis­
ruption of skin vascularization may lead to impaired 
wound healing. Additionally, intra­abdominal pressure 
may lead to lateral detachment of the prosthesis, 
resulting in the higher recurrence rates. The sublay 
mesh technique protects the mesh from bacterial 
contamination while minimizing contact with the bowel 
because the mesh is enveloped in well­vascularized 
tissue, whereas the fascia and peritoneum form a 
natural barrier between prosthesis and abdominal 
organs. This technique reduces the risk of infection, 
adhesion or fistulation. The anatomic positions of the 
sublay and intraperitoneal mesh technique are more 
attractive because of the benefits from intra-abdominal 
pressures, which help to keep the mesh in place.
Concerning laparoscopic vs open parastomal hernia 
repair, this review shows similar results regarding hernia 
recurrence (18% vs 13.5%; p = 0.37), wound infection 
(2.4% vs 3%; p = 0.79) and mesh infection (3.6% 
vs 2.3%; p = 0.50). However, a significantly lower 
rate of other complications was seen with open repair 
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(23.8% vs 12.8%; p < 0.0001), which was mostly due 
to the high occurrence of seroma formation in three 
laparoscopic repair studies[5,8,31] .
When performing laparoscopic intraperitoneal 
repair there was a significantly lower recurrence rate 
of parastomal hernia using the Sugarbaker technique 
compared to the keyhole technique (10.9% vs 35.6%, 
OR = 0.35; 95%CI: 0.21-0.59; p ≤ 0.0001). Re-
markably, it appears that all failures using the keyhole 
technique were related to the use of an e-PTFE-
mesh. As noted by Hansson et al[9], using the keyhole 
technique estimation of the size of the hole is difficult 
as mesh shrinkage may result in enlargement of the 
central hole and reherniation. 
Unfortunately, the recurrence rate is still up to 
one third after mesh repair of parastomal hernias. 
Our systematic review with meta­analysis shows that 
prevention of parastomal hernia by the use of mesh 
at the time of stoma formation reduces the incidence 
of parastomal hernia significantly compared to the 
conventional stoma group (14.9% vs 46.8% OR = 
0.20; 95%CI: 0.08­0.50; p ≤ 0.0006). Interestingly, 
placement of preventive mesh did not result in 
increased wound infection or mesh infection. Recently 
published reviews also confirm our conclusion that 
prophylactic insertion of a mesh when forming a stoma 
prevents parastomal hernia without increasing the 
incidence of wound infections or other mesh­related 
complications[56,57].
One point of discussion remains whether universal 
reinforcement is expedient and cost­effective. Other 
non­mesh prophylactic measures can be considered, 
such as lateral rectus abdominis positioned or extra­
peritoneal positioned stomas[58,59]. Most patients who 
develop a parastomal hernia are asymptomatic. 
However, complications due to an untreated parastomal 
hernia (incarceration, obstruction, strangulation) can 
be severe and are associated with significant morbidity 
and mortality. Identification of patients in whom 
reinforcement is beneficial is essential as the patient 
can avoid unnecessary longer operative time, costs and 
possible long­term complications associated with mesh 
placement. As noted by Hotouras et al[60], risk factors 
for parastomal hernia formation include abdominal 
obesity, increasing age, corticosteroid use, poor nutri­
tional status, increased intra­abdominal pressure, 
connective tissue disorders and other disorders that 
predispose patients to wound infection such as dia­
betes. Factors that need to be considered include the 
reason for the stoma (temporary or permanent stoma), 
patient co­morbidity, chance of reoperations and 
risk factors concerning parastomal hernia formation. 
Patients undergoing stoma formation with short life 
expectancies will often not survive long enough to 
develop a parastomal hernia, and patients who are 
healthy enough to undergo stoma reversal before 
hernia occurrence would not benefit from prophylactic 
mesh placement. 
Median direct costs for complex ventral hernia 
repairs with biologic mesh ($16970) is more than twice 
the amount compared to repairs with synthetic mesh 
($7590)[61]. Parastomal hernia repair probably costs 
less due to the need for smaller meshes; however, a 
substantial cost difference is expected to remain. Figel 
et al[62] calculated that by using a bio­prosthetic and 
considering a 30% incidence of surgical management 
of parastomal hernia repair, it would be cost­effective 
if the prosthesis cost less than $4312. The decision to 
place prophylactic mesh after stoma formation must be 
patient tailored and may certainly be justified in selected 
patients. However, standard application in all patients 
does not seem warranted. More randomized controlled 
trials with adequate power for risk stratification and 
subsequent costs of usage of biologic and synthetic 
mesh are needed. 
Most of the studies that were included are retro­
spective cohorts (level 3 evidence), which could 
introduce selection and information bias and are affe­
cted by heterogeneity. Most study populations were 
diverse with different types of stomas and indications 
for the initial surgery. The high recurrence rate 
regarding biologic parastomal mesh repairs was mostly 
determined by one study: A 75% recurrence rate of 16 
stoma repairs lateral to the rectus sheath compared to a 
27% rate when the repair was within the rectus sheath. 
As noted by Smart et al[4], parastomal hernia repairs 
where the stoma is lateral to the rectus sheath had a 
significantly higher risk of recurrence and suggested 
that this higher risk was likely due to the inherent 
strength of the tissue onto which the onlay mesh was 
sutured.
Unfortunately, reporting was insufficient to allow 
proper stratification for individual risk factors for 
parastomal hernia. Follow­up time and diagnostic 
modalities used for determining recurrence rates had a 
strong impact on the outcome. The longer the follow­
up period was, the more recurrences were found. In 
addition, the diagnostic modalities differ in terms of 
sensitivity and specificity. Some recurrences found 
may be of no clinical relevance. Reported follow-up 
periods within and between studies varied from 7 mo 
to 51 mo. As recurrence occurs mostly in the first years 
after operation a minimum follow up of 12 mo seems 
appropriate.
Definitions of parastomal hernia, wound infection 
and mesh infection were ill-defined in most studies, and 
the modality of determining hernia recurrence (e.g., 
clinical evaluation or CT imaging) was often not clearly 
stated. Therefore, the results of this review should be 
interpreted with care.
In an effort to reduce the effect of low quality 
studies, we excluded the high risk of bias randomized 
controlled trials for the prophylactic mesh meta­
analysis. Only three studies considered of sufficient 
methodological quality remained, and a second meta-
analysis was performed[20,23,40]. No significant difference 
was found in the occurrence of parastomal hernia when 
comparing the prophylactic group to the conventional 
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group (OR = 0.33; 95%CI: 0.09-1.20; p = 0.09).
However, provided the large amount of parastomal 
hernia repairs included in the current report, meaningful 
conclusions may be drawn regarding optimal surgical 
management of synthetic and biologic mesh repair in 
parastomal hernia recurrence. 
Clinical implications
The current evidence suggests there is no superiority 
of (more expensive) biologic mesh over synthetic mesh 
for parastomal hernia repairs after parastomal hernia 
recurrence, wound infection and mesh infection. In the 
context of cost­effective healthcare, careful consideration 
must be taken in choosing the types of materials to 
use[55]. Sublay seemed to be the most advantageous 
anatomic position of the mesh, as this position resulted 
in the lowest recurrence and protects the mesh from 
bacterial contamination while minimizing contact with 
the bowel. No difference was found for parastomal hernia 
recurrence between open or laparoscopic parastomal 
hernia repairs. When performing laparoscopic repair, 
the keyhole technique should be abandoned in favour of 
the Sugarbaker technique when using an ePTFE-mesh 
because of much higher recurrence rates. As shown by 
Wara et al[5], the keyhole technique can be considered 
when using a polypropylene­based mesh or with open 
parastomal keyhole hernia repairs.
Prophylactic mesh placement at the initial surgery 
significantly reduced parastomal hernia occurrence on 
the mid­long term without increasing wound infection or 
mesh infection. However, it has yet to become clear what 
the long­term results will be. The number of recurrences 
will increase over time, though at a slower pace than 
in the first few years after mesh placement. The same 
applies to some specific long-term side effects such as 
mesh infection and mesh-related fistulas. Although their 
incidence may be low, their impact is disproportionately 
high.
Identification of patients in whom reinforcement 
is mandatory is essential, as the patient can avoid 
unnecessary longer operative time, costs and possible 
long­term complications associated with mesh place­
ment. 
Altogether there is still not enough evidence to 
recommend the use a biologic mesh over synthetic 
mesh under contaminated conditions in general and 
specifically not for parastomal hernia repair. Prophylactic 
mesh reinforcement during stoma formation significantly 
reduces parastomal hernia occurrence regardless of mesh 
type. Yet, a significant number of patients will develop 
asymptomatic parastomal hernia and there are no data 
on long term effects of preventive mesh placement. 
Therefore, it is essential to select the right patient for 
whom prophylactic reinforcement is mandatory.
COMMENTS
Background
Parastomal hernia develops in 50% of patients. Hernias are often asymptomatic 
and managed with conservative treatments; however, 11% to 70% of 
patients undergo surgery due to discomfort, pain, obstructive symptoms and 
cosmetic dissatisfaction. Although standard care is mesh repair, prevention by 
prophylactic mesh placement is gaining popularity. The use of biologic mesh 
is becoming more popular as it claims less infections with sustained durability 
of the repair compared to synthetic mesh. The primary aim of the current 
study was to compare biologic and synthetic mesh use for the treatment and 
prevention of parastomal hernia by systematic review and meta-analysis of 
available data in the literature. The secondary aim was to evaluate different 
anatomical positions and surgical techniques concerning parastomal hernia 
repair.
Research frontiers
The recurrence rate of parastomal hernia is the lowest after mesh repair 
(0%-33%), whereas primary fascial closure (46%-100%) and relocation of the 
stoma (0%-76%) result in much higher rates. Although low recurrence rates are 
reported after synthetic mesh repair, concerns have been raised regarding the 
safety of synthetic meshes in (potentially) contaminated fields due to the risk of 
mesh infection and subsequent removal.
Innovations and breakthroughs
Biologic mesh was first introduced in the 1980s and was developed with the 
concept that due to its bio-degradable nature, it has the potential to ameliorate 
problems in infected and contaminated fields. No clear answer can be given as 
to whether there is a difference in the clinical outcomes between synthetic and 
biologic mesh repairs. The high prevalence of parastomal hernia and difficulty 
of repair have led to a shift of focus from repair towards prevention using 
prophylactic mesh reinforcement at the time of stoma formation.
Applications
This review and meta-analysis suggests there is no superiority of biologic over 
synthetic mesh for parastomal hernia repair after parastomal hernia recurrence, 
wound infection and mesh infection. Prophylactic mesh reinforcement during 
stoma formation significantly reduces parastomal hernia occurrence regardless 
of the mesh type. Identification of patients for whom reinforcement is mandatory 
is essential, and mesh reinforcement should be reserved for selected patients.
Terminology
Ostomy formation requires the creation of a full-thickness defect within the 
abdominal wall. Parastomal hernia is a type of incisional hernia that allows 
protrusion of abdominal contents through an abdominal wall defect that is 
created. Both synthetic mesh and biologic mesh (acellular collagen matrix) are 
used in parastomal hernia repair. There are various approaches regarding the 
anatomic position of the mesh during parastomal hernia repair. Meshes can be 
implanted in an inlay (between the fascia), onlay (over the fascia), sublay (below 
the anterior fascia and muscular level but above peritoneum) or underlay 
(intraperitoneal) position. Laparoscopic repair involves the intraperitoneal 
technique, and open repair may involve any of the anatomical planes of the 
mesh. When performing intraperitoneal repair, the choice can be made between 
the Sugarbaker and keyhole repair technique.
Peer-review
In this systematic review, the authors have presented a thorough and critical 
analysis of biologic and synthetic mesh use for the treatment and prevention 
of parastomal hernias. With a focus on hernia recurrence in the absence of 
rigorous data in the literature, the current review contributes to the increased 
understanding of parastomal hernias.
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